Skip to main content
. Author manuscript; available in PMC: 2014 Aug 5.
Published in final edited form as: Mol Pharm. 2013 Jul 11;10(8):2880–2890. doi: 10.1021/mp300729y

Table 3.

IC50 of free PEG2K-VE, PEG2K-VE2, PEG5K-VE and PEG5K-VE2 micelles in different cancer cell lines

IC50(µg/mL)
PEG2K-VE PEG2K-VE2 PEG5K-VE PEG5K-VE2
4T1.2 64.30 N/A 30.98 726.44
NCI/ADR-RES 1.04 74.83 6.05 33.83
MCF-7 223.78 839.89 176.29 637.71
MDA-MB-231 66.82 403.93 61.52 224.98
PC-3 79.17 N/A 75.91 366.79